vimarsana.com

Page 2 - Cell Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OrganaBio unveils new division for vaccine and cell and gene therapy clinical trials

OrganaBio, a contract technology development and manufacturing organization (CTDMO) specializing in solutions for cell and immunotherapy development, has launched a new division.

Global Cell Therapy Technologies Market Worth $7 8 Billion by 2027: Thermo Fisher Scientific, Merck, Danaher, BD, Lonza Group, and Sartorius Dominate

vimarsana © 2020. All Rights Reserved.